Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Operating Expenses (2019 - 2025)

IDEAYA Biosciences' Operating Expenses history spans 7 years, with the latest figure at $105.4 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 30.23% year-over-year to $105.4 million; the TTM value through Dec 2025 reached $378.0 million, up 13.19%, while the annual FY2025 figure was $378.0 million, 13.19% up from the prior year.
  • Operating Expenses for Q4 2025 was $105.4 million at IDEAYA Biosciences, up from $99.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $151.1 million in Q4 2024 and bottomed at $16.4 million in Q1 2021.
  • The 5-year median for Operating Expenses is $38.9 million (2023), against an average of $53.1 million.
  • The largest annual shift saw Operating Expenses skyrocketed 229.71% in 2024 before it crashed 30.23% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $21.3 million in 2021, then skyrocketed by 42.82% to $30.5 million in 2022, then skyrocketed by 50.46% to $45.8 million in 2023, then surged by 229.71% to $151.1 million in 2024, then plummeted by 30.23% to $105.4 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Operating Expenses are $105.4 million (Q4 2025), $99.4 million (Q3 2025), and $88.8 million (Q2 2025).